Skip to main content
Clinical Trials/NCT00250523
NCT00250523UnknownNot Applicable

Mathematical Modeling of the Acute Inflammatory Response Following Injury

National Institute of General Medical Sciences (NIGMS)1 site in 1 country520 target enrollmentStarted: February 2003Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
520
Locations
1
Primary Endpoint
Multiple Organ Failure

Study Overview

Brief Summary

The purpose of this research study is to gather clinical and biologic information from severely injured patients to better understand and characterize the host response to injury and inflammation across several domains. This information may improve outcome prediction, improve clinical treatment of injured patients, and permit the construction of non-biologic computerized models of illness that can be utilized to represent the host response in future research efforts. This study is designed as the calibration of a mathematical model of this response with predictive capabilities.

The central hypothesis governing this study is that adaptive immune elements are crucial to determining the outcome of complex inflammatory scenarios. We propose to test these hypotheses in the following interrelated Specific Aims:

Specific Aim 1: To develop a robust mathematical model describing trauma/hemorrhage-induced inflammation in humans, its pathologic consequences, and possible therapies.

Specific Aim 2: To translate the mathematical model to humans and create software aimed at individualized clinical decision-making.

Specific Aim 3: To determine the prevalence of an IL-1 receptor-associated kinase (IRAK-1) variant haplotype located on the X-chromosome in an injured population, and to characterize differences in the pro-inflammatory response across gender, relative to the IRAK-1 haplotype.

Specific Aim 4: To determine if increased arginase activity previously observed in isolated peripheral blood mononuclear cells of trauma patients is a consequence of the presence of contaminating activated granulocytes or a particular subset of an arginase positive monocyte subset.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Multiple Organ Failure

Time Frame: 48 hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
National Institute of General Medical Sciences (NIGMS)
Sponsor Class
Nih
Responsible Party
Principal Investigator
Principal Investigator

Dr Jason L Sperry

Professor of Surgery and Critical Care Medicine

National Institute of General Medical Sciences (NIGMS)

Study Sites (1)

Loading locations...

Similar Trials